Skip to main content

William O. Suddath, MD

Original Contribution
08/01/2008
The major cause of mortality in dialysis patients is attributable to cardiovascular diseases.1,2 The higher prevalence of coronary artery disease in this population is thought to be related to a higher risk factor distribution, platelet...
The major cause of mortality in dialysis patients is attributable to cardiovascular diseases.1,2 The higher prevalence of coronary artery disease in this population is thought to be related to a higher risk factor distribution, platelet...
The major cause of mortality in...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
05/04/2009
ABSTRACT: Background. Recent data suggest a clinical benefit with the systematic use of thrombus aspiration (TA) for the treatment of ST-elevation myocardial infarction (STEMI). Nevertheless, the impact of TA as a treatment strategy for stent...
ABSTRACT: Background. Recent data suggest a clinical benefit with the systematic use of thrombus aspiration (TA) for the treatment of ST-elevation myocardial infarction (STEMI). Nevertheless, the impact of TA as a treatment strategy for stent...
ABSTRACT: Background. Recent...
05/04/2009
Journal of Invasive Cardiology
Original Contribution
09/05/2009
ABSTRACT: Background. Stents are used to treat the first and even successive episodes of in-stent restenosis (ISR). Methods. In 18 patients (19 lesions), intravascular ultrasound (IVUS) was performed after placement of a stent for a...
ABSTRACT: Background. Stents are used to treat the first and even successive episodes of in-stent restenosis (ISR). Methods. In 18 patients (19 lesions), intravascular ultrasound (IVUS) was performed after placement of a stent for a...
ABSTRACT: Background. Stents are...
09/05/2009
Journal of Invasive Cardiology
Original Contribution
06/28/2011
ABSTRACT: Background. The process of in-stent neointimal hyperplasia (NIH) between drug-eluting stents (DES) and bare metal stents (BMS) might be different. We compared in vivo composition of in-stent NIH between DES and BMS using virtual...
ABSTRACT: Background. The process of in-stent neointimal hyperplasia (NIH) between drug-eluting stents (DES) and bare metal stents (BMS) might be different. We compared in vivo composition of in-stent NIH between DES and BMS using virtual...
ABSTRACT: Background. The...
06/28/2011
Journal of Invasive Cardiology
Original Contribution
09/02/2015
This study compares the clinical outcomes of lesion preparation with rotational atherectomy, plain old balloon angioplasty, or cutting-balloon angioplasty in patients with heavily calcified coronary lesions who were treated with drug-eluting...
This study compares the clinical outcomes of lesion preparation with rotational atherectomy, plain old balloon angioplasty, or cutting-balloon angioplasty in patients with heavily calcified coronary lesions who were treated with drug-eluting...
This study compares the clinical...
09/02/2015
Journal of Invasive Cardiology
Original Contribution
05/29/2015
This study aimed to evaluate the safety and efficacy of everolimus-eluting stent (EES) use compared with first-generation drug-eluting stent (DES) use in diabetic patients undergoing multivessel percutaneous coronary intervention. In diabetic...
This study aimed to evaluate the safety and efficacy of everolimus-eluting stent (EES) use compared with first-generation drug-eluting stent (DES) use in diabetic patients undergoing multivessel percutaneous coronary intervention. In diabetic...
This study aimed to evaluate the...
05/29/2015
Journal of Invasive Cardiology
08/01/2008
Aortic stenosis (AS) is prevalent in 2–7% of the population over 65 years of age.1 Atherosclerotic coronary artery disease (CAD) coexists in 27–43% of patients with AS.2 Management of CAD in patients with AS poses special problems since...
Aortic stenosis (AS) is prevalent in 2–7% of the population over 65 years of age.1 Atherosclerotic coronary artery disease (CAD) coexists in 27–43% of patients with AS.2 Management of CAD in patients with AS poses special problems since...
Aortic stenosis (AS) is...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Recent randomized trials have established that patients who present with acute coronary syndrome (ACS) non-ST-elevation myocardial infarction (MI) may be managed with low-molecular weight heparin (LMWH) followed by early angiography and by...
Recent randomized trials have established that patients who present with acute coronary syndrome (ACS) non-ST-elevation myocardial infarction (MI) may be managed with low-molecular weight heparin (LMWH) followed by early angiography and by...
Recent randomized trials have...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Clopidogrel is an oral antiplatelet agent which selectively and irreversibly inhibits the platelet adenosine 5'-diphosphate (ADP) receptor. Antiplatelet effect is synergistic when administered with aspirin. Dual antiplatelet therapy with...
Clopidogrel is an oral antiplatelet agent which selectively and irreversibly inhibits the platelet adenosine 5'-diphosphate (ADP) receptor. Antiplatelet effect is synergistic when administered with aspirin. Dual antiplatelet therapy with...
Clopidogrel is an oral...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
12/15/2015
This study aimed to evaluate the patient characteristics and outcomes of venoarterial extracorporeal membrane oxygenation with refractory cardiogenic shock in the setting of AMI.
This study aimed to evaluate the patient characteristics and outcomes of venoarterial extracorporeal membrane oxygenation with refractory cardiogenic shock in the setting of AMI.
This study aimed to evaluate the...
12/15/2015
Journal of Invasive Cardiology